These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 27408341)

  • 1. Plasma concentrations of buprenorphine following a single subcutaneous administration of a sustained release formulation of buprenorphine in sheep.
    Zullian C; Lema P; Lavoie M; Dodelet-Devillers A; Beaudry F; Vachon P
    Can J Vet Res; 2016 Jul; 80(3):250-3. PubMed ID: 27408341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of a Sustained Release Formulation of Buprenorphine After Intramuscular and Subcutaneous Administration to American Kestrels ( Falco sparverius ).
    Guzman DS; Knych HK; Olsen GH; Paul-Murphy JR
    J Avian Med Surg; 2017 Jun; 31(2):102-107. PubMed ID: 28644085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics and analgesic effects of extended-release buprenorphine administered subcutaneously in healthy dogs.
    Barletta M; Ostenkamp SM; Taylor AC; Quandt J; Lascelles BDX; Messenger KM
    J Vet Pharmacol Ther; 2018 Aug; 41(4):502-512. PubMed ID: 29521421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of a single subcutaneous dose of sustained release buprenorphine in northern elephant seals (Mirounga angustirostris).
    Molter CM; Barbosa L; Johnson S; Knych HK; Chinnadurai SK; Wack RF
    J Zoo Wildl Med; 2015 Mar; 46(1):52-61. PubMed ID: 25831576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and Antinociceptive Activity of Sustained-Release Buprenorphine in Sheep.
    Walkowiak KJ; Graham ML
    J Am Assoc Lab Anim Sci; 2015 Nov; 54(6):763-8. PubMed ID: 26632786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic and pharmacodynamic modelling after subcutaneous, intravenous and buccal administration of a high-concentration formulation of buprenorphine in conscious cats.
    Doodnaught GM; Monteiro BP; Benito J; Edge D; Beaudry F; Pelligand L; Steagall P
    PLoS One; 2017; 12(4):e0176443. PubMed ID: 28445495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of buprenorphine after intravenous administration in the mouse.
    Yu S; Zhang X; Sun Y; Peng Y; Johnson J; Mandrell T; Shukla AJ; Laizure SC
    J Am Assoc Lab Anim Sci; 2006 May; 45(3):12-6. PubMed ID: 16642964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic modelling of intravenous, intramuscular and subcutaneous buprenorphine in conscious cats.
    Steagall PV; Pelligand L; Giordano T; Auberger C; Sear JW; Luna SP; Taylor PM
    Vet Anaesth Analg; 2013 Jan; 40(1):83-95. PubMed ID: 22998333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of buprenorphine hydrochloride following intramuscular and intravenous administration to American kestrels (Falco sparverius).
    Gustavsen KA; Guzman DS; Knych HK; Petritz OA; Olsen GH; Paul-Murphy JR
    Am J Vet Res; 2014 Aug; 75(8):711-5. PubMed ID: 25061701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravenous and intramuscular buprenorphine in the horse.
    Davis JL; Messenger KM; LaFevers DH; Barlow BM; Posner LP
    J Vet Pharmacol Ther; 2012 Feb; 35(1):52-8. PubMed ID: 21392040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of 2 formulations of buprenorphine in macaques (Macaca mulatta and Macaca fascicularis).
    Nunamaker EA; Halliday LC; Moody DE; Fang WB; Lindeblad M; Fortman JD
    J Am Assoc Lab Anim Sci; 2013 Jan; 52(1):48-56. PubMed ID: 23562033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic modelling of intravenous buprenorphine in conscious horses.
    Love EJ; Pelligand L; Taylor PM; Murrell JC; Sear JW
    Vet Anaesth Analg; 2015 Jan; 42(1):17-29. PubMed ID: 24735059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Use Disorder.
    Laffont CM; Gomeni R; Heidbreder C; Jones JP; Nasser AF
    J Clin Pharmacol; 2016 Jul; 56(7):806-15. PubMed ID: 26479717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentrations of buprenorphine after oral and parenteral administration in male mice.
    Kalliokoski O; Jacobsen KR; Hau J; Abelson KS
    Vet J; 2011 Feb; 187(2):251-4. PubMed ID: 20045358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic properties of buprenorphine after a single intravenous administration in healthy volunteers: a randomized, double-blind, placebo-controlled, crossover study.
    Escher M; Daali Y; Chabert J; Hopfgartner G; Dayer P; Desmeules J
    Clin Ther; 2007 Aug; 29(8):1620-31. PubMed ID: 17919544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of subcutaneous and intramuscular administrated buprenorphine in New Zealand White rabbits.
    Askar R; Fredriksson E; Manell E; Hedeland M; Bondesson U; Bate S; Olsén L; Hedenqvist P
    BMC Vet Res; 2020 Nov; 16(1):436. PubMed ID: 33176781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the efficacy and adverse effects of sustained-release buprenorphine hydrochloride following subcutaneous administration and buprenorphine hydrochloride following oral transmucosal administration in cats undergoing ovariohysterectomy.
    Catbagan DL; Quimby JM; Mama KR; Rychel JK; Mich PM
    Am J Vet Res; 2011 Apr; 72(4):461-6. PubMed ID: 21453146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine.
    Kuhlman JJ; Lalani S; Magluilo J; Levine B; Darwin WD
    J Anal Toxicol; 1996 Oct; 20(6):369-78. PubMed ID: 8889672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of Absorption of a Sustained-release Buprenorphine Formulation Administered Subcutaneously to Athymic Nude Rats.
    Page CD; Sarabia-Estrada R; Hoffman RJ; Lo CP; Gades NM
    J Am Assoc Lab Anim Sci; 2019 Sep; 58(5):597-600. PubMed ID: 31362805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous and sublingual buprenorphine in horses: pharmacokinetics and influence of sampling site.
    Messenger KM; Davis JL; LaFevers DH; Barlow BM; Posner LP
    Vet Anaesth Analg; 2011 Jul; 38(4):374-84. PubMed ID: 21501371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.